Scientific Sense

Scientific Sense

By Gill Eapen
Emerging ideas in Science, Policy, Economics, and Technology. Discussions with leading academics and experts.

/ Blog: www.scientificsense.com / Platform: www.decisionoptions.com
Where to listen
Apple Podcasts Logo
Breaker Logo
Castbox Logo
Google Podcasts Logo
Overcast Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

Prof. Marion Nestle, Professor Emerita of Nutrition, Food Studies, and Public Health, at New York University

Scientific Sense

Sponsor: Anchor

Scientific Sense

Go to next audioGo to next audio
Go to prev audioGo to prev audio
1x
Prof. M. V. Lee Badgett, Professor of economics and co-director of the Center for Employment Equity at the University of Massachusetts Amherst
The economic impact of LGBT rights in firms and countries, policy trends, wage gaps and reasons for optimism Prof. M. V. Lee Badgett is a professor of economics and co-director of the Center for Employment Equity at the University of Massachusetts Amherst. She is also a Williams Distinguished Scholar at UCLA’s Williams Institute. Her research focuses on economic inequality for LGBT people, including wage gaps, employment discrimination, and poverty, and on the global cost of homophobia and transphobia. Her latest book is The Economic Case for LGBT Equality: Why Fair and Equal Treatment Benefits Us All (Beacon Press, 2020).
40:14
July 15, 2020
Prof. Rory Cooper, Professor of Rehabilitation Science and Technology, and Orthopedic Surgery at the University of Pittsburgh
Computer Assisted Mobility, Intelligent Wheelchair design, Human/Machine interactions, and Human Engineering Research Laboratories. Prof. Rory Cooper holds several positions including Associate Dean for Inclusion and Paralyzed Veterans of America, Professor of Rehabilitation Science and Technology, and Orthopedic Surgery at the University of Pittsburgh. He is also the Founding Director and the VA Senior Research Career Scientist at the Human Engineering Research Laboratories. He is also a Professor of Physical Medicine and Rehabilitation at the Uniformed Services University of the Health Sciences.
37:34
July 14, 2020
Prof. James Bashkin, Professor of Chemistry and Bio-Chemistry at the University of Missouri, St.Louis.
Cheaper and faster sterilization of PPE, HPV eliminating antiviral and anticancer agents,  Modulating DNA with polyamides, Green Chemistry  Prof. James Bashkin is a Professor of Chemistry and Bio-Chemistry at the University of Missouri, St.Louis. Prior to this, he was an NIH postdoctoral fellow at Harvard before joining Monsanto Corporate Research, which later became Pharmacia and then Pfizer. His recent research interest has been at the interface of chemistry and biology, in areas such as "chemical genomics," the design of antiviral and anticancer agents, and Green Chemistry.
44:24
July 11, 2020
Prof. Liran Carmel, Professor of Computational Biology at the Hebrew University of Jerusalem in Israel
Human evolution, Out of Africa migrations, Neanderthals and Denisovans, DNA methylation effects on the body parts, Gene organizer, Epigenetics in assessing ancient environments and behavior of humans. Prof. Liran Carmel is a professor of computational biology at the Hebrew University of Jerusalem in Israel. Liran has won many awards, including the Michael Milken prize, the Farkash award, and the Eshkol fellowship. Liran is studying a host of topics in molecular evolution, RNA biology, and genetics and is particularly interested in human evolution and in understanding the very recent evolutionary adaptations that led to the development of human-specific traits. He is among the founders of paleo-epigenetics, a field of study where epigenetic signals are reconstructed in ancient genomes, thus allowing to obtain information on ancient gene activity patterns.
42:32
July 9, 2020
Mr. Joel Peterson, recently retired Chairman of JetBlue Airways, former Chairman of The Hoover Institution, and the Founder of Peterson Partners
Trust as an operating system, Entrepreneurship, Leadership, Types of leaders, Entrepreneurial leadership, Creating successful companies and Startups  Joel Peterson is the 12-year Chairman of JetBlue Airways, retiring in May 2020, former Chairman of The Hoover Institution, and the Founding Partner of Peterson Partners, a Salt Lake City-based investment management firm with $1B under management. Since 1992, Peterson has been on the faculty at the Graduate School of Business at Stanford University, teaching courses in real estate investment, entrepreneurship, and leadership.
42:04
July 7, 2020
Prof. Eleftherios Mylonakis, Professor of Molecular Microbiology and Immunology at Brown University
Antimicrobial research, surrogate invertebrate hosts, in vivo high throughput screening, methicillin-resistant MRSA, colonization, and the need for fast and accurate diagnostics. Prof. Eleftherios Mylonakis is a Professor of Infectious Diseases at Brown University and the Chief of Infectious Diseases at Rhode Island and Miriam Hospitals. He is also the Director of the COBRE Center for Antimicrobial Resistance and Therapeutic Discovery. He is Assistant Dean for Outpatient Investigations and Director of the Center for Outpatient and Longitudinal Medical Research at the Alpert Medical School of Brown University and Professor of Molecular Microbiology and Immunology. He has 8 patents and almost 400 articles in peer-reviewed literature.
53:48
July 6, 2020
Prof. Brian Keating, Professor of Physics at the Center for Astrophysics & Space Sciences at the University of California, San Diego
Background Imaging of Cosmic Extragalactic Polarization, Simons Observatory, Origins of the Universe, Hubble constant discrepancy, Multiverse  Prof. Brian Keating is a Professor of Physics at the Center for Astrophysics & Space Sciences at the University of California, San Diego. Prof. Keating's research area is the study of the cosmic microwave background and its relationship to the origin and evolution of the universe. In 2001 he conceived the first BICEP experiment (Background Imaging of Cosmic Extragalactic Polarization), located at the South Pole. Later he became Director of the Simons Observatory, co-located with the ACT telescopes in northern Chile. The project includes over 250 collaborators from over 30 institutions around the world.
58:16
July 4, 2020
Prof. Bart Selman, Professor of Computer Science at Cornell University
Artificial Intelligence, Artificial General Intelligence, Non-human intelligence, Machine Reasoning, Policy, and the AI future of society Prof Bart Selman is a Professor of Computer Science at Cornell University. He is the incoming President of the Association for the Advancement of Artificial Intelligence (AAAI), the main international professional society for AI researchers and practitioners. Last year, he co-chaired a national study to determine a 20-year Roadmap for AI research, to guide US government investments in AI research. Prof. Selman was previously at AT&T Bell Laboratories. He has authored numerous publications and has won many awards.
51:27
July 2, 2020
Mr. Jim Jordan, Distinguished Service Professor of Healthcare & Biotechnology Management at Carnegie Mellon University
The start-up ecosystem in life sciences, Stakeholders in a start-up, Basic v/s translational research, and health systems  Mr. Jim Jordan is the President of the Pittsburgh Life Sciences Greenhouse and the Managing Director of the Accelerator Funds. Jim has served as a Distinguished Service Professor of Healthcare & Biotechnology Management at Carnegie Mellon University. He has written two books; Innovation, Commercialization, and Start-ups in Life Sciences, The Intellectual Property Pyramid Assessment, and is currently working on his third book, Health Systems.
43:48
July 1, 2020
Prof. Anup Malani, Professor at the University of Chicago Law School & Medical School
Adaptive control for COVID-19 in India, A field experiment for health insurance in India, the evolution of influenza with vaccination Prof Anup Malani is a Professor at the University of Chicago Law School and a Professor at the Pritzker School of Medicine at the University of Chicago.  He is also a Research Associate at the National Bureau of Economic Research in Boston, a Senior Fellow at the Schaeffer Center at the University of Southern California, and an editor at the Journal of Law and Economics. Prof. Malani is the co-founder and Faculty Director of the International Innovation Corps, a social service program that sends teams of US and foreign university graduates to work on innovative development projects with government officials in India.
59:00
June 30, 2020
Prof. Steve Greenbaum, Professor of Physics at Hunter College in the City University of New York
Battery technologies, species of electrolytes, materials science innovation, the safety of products, and the need for inclusion in education Prof. Steve Greenbaum is a Professor of Physics at Hunter College in the City University of New York and a Fellow of the American Physical Society. Prof. Greenbaum's main research interest involves spectroscopic studies of disordered solids by magnetic resonance and synchrotron x-ray absorption, most of which have recently centered on materials for electrochemical energy storage and conversion. He has authored or co-authored over 260 peer-reviewed publications and given over 60 invited talks at national or international conferences.
38:09
June 27, 2020
Prof. Kenneth Kaitin, Professor of Public Health and Medicine at Tufts School of Medicine
Pharmaceutical R&D trends and costs, Value chain paradigms, Basic v/s translational research, Investment needs, and COVID 19 Prof. Kenneth Kaitin is a professor of Public Health and Medicine at Tufts School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in Shanghai, and a consultant to the U.S. Department of Defense on bioterror countermeasures. Ken’s research focuses on the economic, scientific, regulatory, and political factors that affect pharmaceutical development.
47:39
June 26, 2020
Prof. Robert Bird, Professor of Business Law and the Chair in Business Ethics at the University of Connecticut
Future of business law, Corporate legal strategy, Turning compliance into a competitive advantage Prof. Robert Bird is a Professor of Business Law and the Chair in Business Ethics at the University of Connecticut. Robert's wide-ranging research focuses on corporate social responsibility, corporate compliance, employment law, legal strategy, and the intersection of law and business. His work has been published widely and he has received numerous teaching and research awards and is currently the President-Elect of the Academy of Legal Studies in Business.
38:34
June 25, 2020
Prof. David Ikenberry, Professor of Finance at the University of Colorado
Investment-q paradox,  persistent investment decline, Tobin's q decomposition, asset utilization as a driver of investment rate, and failure of common explanations.   Prof. David Ikenberry was the Chair of Finance at the University of Illinois at Urbana-Champaign and the Associate Dean of the Executive programs. Later he served as the Dean of the Leeds School of Business at the University of Colorado, Boulder, and now serves as the full professor in the School. He was an early pioneer among researchers examining long-horizon stock returns, particularly returns subsequent to major corporate news events. Much of his work relates to behavioral finance and the extent to which news is incorporated into market prices. His most noted work has studied open market stock repurchase programs. Please excuse the slight overlap in the audio.
57:24
June 24, 2020
Prof. George Perry, Professor of Biology and Chemistry at The University of Texas at San Antonio
Alzheimer's disease, oxidative stress, mitochondria abnormalities, diagnostics, amyloid-beta plaques, aging Prof. George Perry is a Professor of Biology and Chemistry at The University of Texas at San Antonio. Prof Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.  Perry's research is primarily focused on how Alzheimer’s disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals.
42:28
June 23, 2020
Prof. Richard Mammone, Professor of engineering and business at Rutgers University.
Artificial Intelligence, Breast cancer diagnostics, Teleradiology, Social return to technology commercialization  Prof. Richard Mammone, a professor of engineering and business at Rutgers University. He is a fellow of the National Academy of Inventors, recipient of the Thomas Edison Patent Award and inductee of the New Jersey Inventors Hall of Fame. He has published over 200 papers and has 30 patents. He was a founding editorial board member of the IEEE Neural Network Society and was the Associate Vice President of Innovation and Partnerships of Rutgers.
51:54
June 20, 2020
Prof. Marion Nestle, Professor Emerita of Nutrition, Food Studies, and Public Health, at New York University
Food, Nutrition, Obesity, supply chains, food security Marion Nestle is a Professor of Nutrition, Food Studies, and Public Health, at New York University. She is also a Visiting Professor of Nutritional Sciences at Cornell. Her research and writing examine scientific and socioeconomic influences on food choice and its consequences, emphasizing the role of food industry marketing. She is the author of six prize-winning books. She has received many awards and honors for her excellent teaching, research, and writing.
30:03
June 18, 2020
Professor Stanley Litow of Columbia and Duke University
Public-private partnerships, education systems, ethics and leadership  Dr. Stanley Litow is a Professor at Columbia and Duke University, and serve as Innovator in Residence at Duke. He is a speaker, writer and subject matter expert on Education and Corporate Social Responsibility and had a career in the public, private and not for profit sectors, including President of the IBM Foundation, Deputy Schools Chancellor for New York City, and Founder of Interface. He has served on several Presidential Commissions and currently serves as a Trustee of the State University of New York. He is also a columnist for Barron's.
38:05
June 17, 2020
Prof. Stephen Hinshaw, Professor of Psychology at the University of California, Berkeley and Professor of Psychiatry at UCSF
Mental illnesses, stigma, ADHD, design of education, Berkely girls longitudinal study  Professor Stephen Hinshaw is a Professor of Psychology at the University of California, Berkeley, and Professor of Psychiatry at UCSF.  His work focuses on developmental psychopathology, clinical interventions in attention deficits and hyperactivity, and mental illness stigma.  His excellent teaching and research over the years brought him numerous awards including those from the Society for Science of Clinical Psychology, the Society for Research in Child Development, and the American Psychological Association. He has authored over 360 articles and chapters plus 12 books
54:47
June 16, 2020
Dr. Sara Abiola, Assistant Professor of Health Policy & Management at the Columbia Mailman School of Public Health
Hunger in America, SNAP/Food Stamps, SSTAR Act, Obesity, Decision-making Dr. Sara Abiola is an assistant professor of health policy & management at the Columbia Mailman School of Public Health and co-director of the Better Health Systems Lab that analyzes law, policy, and technological innovations designed to facilitate health systems strengthening and transformation through multisector collaboration and integration. She has constructed legal databases to map noncommunicable disease prevention policy and food policy at the global and national level and currently explores statutory and regulatory mechanisms to integrate the delivery of health and social services to address inequality and the social determinants of health.
41:26
June 15, 2020
Dr. John S. Lyons, Professor of Health Management and Policy at the University of Kentucky
Population health, Transformational Collaborative Outcomes Management (TCOM). Dr. John S. Lyons is a Professor of Health Management and Policy and the Director of the Center of Innovation in Population Health at the University of Kentucky.   After receiving a doctorate in clinical psychology, John has founded the Mental Health Services and Policy Program at Northwestern University, been the inaugural chair of Child and Youth Mental Health at the University of Ottawa, and a Senior Policy Fellow at the University of Chicago.  He has designed and implemented outcomes management approaches in all fifty states and on every continent except Antarctica.
49:41
June 14, 2020
Prof. Mehdi Anwar, Professor of Electrical and Computer Engineering at the University of Connecticut
Memristors, Neuromorphic Computing, Mysteries of the brain and the future of Computing  Dr. Mehdi Anwar is a Professor of Electrical and Computer Engineering at the University of Connecticut. As a Jefferson Science Fellow, he served as Special Adviser for Technology Transfer and Innovation in the office of Intellectual Property Enforcement, Economic Bureau, U. S. Department of State. At present, Dr. Anwar is assisting U. S. Department of State and other U. S. Government organizations and the United Nations Office for the Least Developed Countries, Landlocked Developing Countries, and Small Island Developing States to stand up the newly established United Nations Technology Bank.
42:27
June 13, 2020
Prof. Bruce Mizarch, Professor of Economics at Rutgers University
Microstructures of financial markets, order routing, high-frequency trading, oil prices  ..... Prof. Bruce Mizrach is a professor in the Department of Economics at Rutgers University. He has held appointments at Boston College, the Wharton School, the Federal Reserve Bank of New York,  and NYU Stern School of business. Bruce is the founder and editor of Studies in Nonlinear Dynamics and Econometrics, which is devoted to using the nonlinear analysis to understand economic and financial markets. His most recent work is on the market microstructure of electronic limit order markets in bonds, equities, and commodity markets.
34:21
June 12, 2020
Dr. Scott Friedman, the Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai
Causes of chronic liver diseases, emerging treatments, COVID-19 Dr. Scott Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.
35:47
June 11, 2020
Prof. Jeffrey Townsend of Yale School of Public Health and Yale University
Evolution of cancer, plague, pandemics, COVID, policymaking under uncertainty Jeffrey Townsend is the Elihu Professor of Biostatistics and Ecology and Evolutionary Biology at the Yale School of Public Health and Yale University. He is an experimentalist and a theoretician; someone who performed the first experiments to show how extensively genome-wide gene expression varies in one individual organism to another within a population; who has developed theory to reveal not just what is known, but what is unknown and unknowable in how organisms have descended from their ancestors; who has pioneered both experimental and theoretical approaches enabling us to understand the evolutionary changes that give an organism its form, function, and ability to survive and propagate. Currently, he spends the majority of his time working on evolutionary theory applied to tumor genome sequencing, revealing how cancer evolves from normal tissue to malignant tissue—how cancer evolves within us.
54:12
June 9, 2020
Prof. Warren Powell of Operations Research and Financial Engineering at Princeton University
Decisions under uncertainty, shocks, supply chains, and autonomous vehicles Prof Warren Powell taught at Princeton for almost 40 years, where he was drawn to the opportunity of bringing advanced analytics to the trucking industry which introduced him to the challenge of making high-dimensional decisions (such as assigning drivers to loads) under uncertainty.  This problem guided a lifetime of research in stochastic optimization using approximate dynamic programming. His research produced over 250 papers and two books with the help of 60 graduate students and post-docs, supported by $50 million in research funding.
45:42
June 6, 2020
Prof. Julia Lane, Professor at NYU Wagner Graduate School of Public Service
Democratizing our data - A manifesto. Improving the design of metrics, collection of data, analysis and decision-making at the federal level Prof. Julia Lane is a Professor at the New York University Wagner Graduate School of Public Service and an NYU Fellow for Innovation Analytics. She is a senior advisor in the Office of the Federal CIO at the White House, supporting the implementation of the Federal Data Strategy. She cofounded the Coleridge Initiative, whose goal is to use data to transform the way governments access and use data for the social good through training programs, research projects, and a secure data facility.
40:14
June 3, 2020
Dr. Ian Williams, author, sculptor and biochemist.
Humans, bacteria, intelligence, consciousness, life and everything else Ian Williams was born in England in 1954. He trained as a biochemist at the Universities of Bristol and Oxford and received an MFA from Bennington College in Vermont. He worked for Pfizer for twenty years heading the Molecular Sciences Department and serving in the Research strategy group. He and his wife, Nancy Hutson, have a farm in Connecticut containing over 50 large-scale sculptures that Williams has made over the last decade. Together with Nancy, he has ridden in horseback safaris in many parts of the world. He may be reached at ian.inc@mac.com
1:01:22
May 30, 2020
Dr.Pierre Etienne, co-Director of the Alzheimer’s disease prevention program at McGill University
COVID-19, clinical trial processes, pharmaceutical R&D, vaccine development, use of preventative medications, Alzheimer's disease, PTSD After obtaining his medical degree in Belgium in 1972, Pierre Etienne moved to McGill University, where he did postgraduate work in neurochemistry. There he directed a program on the biochemical, physiological, and neuropathological basis of Alzheimer's disease. After a brief passage in experimental medicine at Ciba-Geigy (now Novartis), he went back to McGill in 1987, dividing his time between the Montreal Neurological Institute and the Allan Memorial Institute. In 1989 he joined Pfizer as Director of Experimental Medicine, responsible for all Phase 2 A programs for US and Japan discovered compounds. In 2003, he became CEO of PhageTech, Inc., a privately-held biotechnology company based in Montreal, Canada. PhageTech exploited a proprietary platform based on phage-bacterial intracellular interactions to research and develop new classes of synthetic antibiotics. Phagetech later became Targanta Therapeutics that went public on NASDAQ (TARG) in the summer of 2008. In December 2009, he started a new life as a physician at the Douglas Institute. In July 2011, he was appointed Director of the Clinical Research Division. He is the co-Director of the Alzheimer’s disease prevention program (Stop-AD).
55:03
May 24, 2020